Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Phase 2

Completed

Conditions: Hematologic Malignancy
Myeloproliferative Disorder

Interventions: Drug: Isavuconazole

First Posted Date: 2017-05-11

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 99

Registration Number: NCT03149055

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Early Phase 1

Active, not recruiting

Conditions: Liver Cancer

Interventions: Drug: Drug Eluting Bead Transarterial Chemoembolization
Drug: Nivolumab

First Posted Date: 2017-05-08

Last Posted Date: 2025-05-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT03143270

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

and more 6 locations

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

Phase 1

Active, not recruiting

Conditions: Moderate to Severe Dysphagia
Esophagogastric Cancer

Interventions: Drug: WST 11-mediated VTP therapy

First Posted Date: 2017-04-28

Last Posted Date: 2025-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT03133650

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States
🇺🇸
Weill Cornell Medical Center (Data Analysis Only), New York, New York, United States
🇮🇱
Weizmann Institute of Science, Reẖovot, Israel

A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

Active, not recruiting

Conditions: Histiocytosis

Interventions: Behavioral: Trail Making Test, Parts A & B
Behavioral: Brief Test of Attention
Behavioral: Symbol Span
Behavioral: Controlled Oral Word Association Test
Behavioral: The Hopkins Verbal Learning Test-Revised
Behavioral: Brief Visuospatial Memory Test-Revised
Behavioral: Hospital Anxiety and Depression Scale
Behavioral: McGill Quality of Life Scale
Diagnostic Test: MR Brain Imaging
Diagnostic Test: Resting state functional MRI
Behavioral: Functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog)

First Posted Date: 2017-04-25

Last Posted Date: 2025-05-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 13

Registration Number: NCT03127709

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 1 locations

A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer

Phase 2

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: durvalumab
Drug: tremelimumab
Radiation: Radiotherapy (RT)
Procedure: ablation

First Posted Date: 2017-04-20

Last Posted Date: 2022-07-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT03122509

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

Phase 2

Active, not recruiting

Conditions: Metastatic Melanoma

Interventions: Drug: ipilimumab
Drug: nivolumab

First Posted Date: 2017-04-20

Last Posted Date: 2025-06-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 70

Registration Number: NCT03122522

Locations: 🇺🇸
JOHNS HOPKINS HOSPITAL (Data Analysis Only), Baltimore, Maryland, United States
🇺🇸
Columbia University (Data Analysis Only), New York, New York, United States
🇺🇸
Brigham and Women's Hospital (Data and Specimen Analysis Only), Boston, Massachusetts, United States

and more 11 locations

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

Phase 1

Completed

Conditions: Metastatic Anaplastic Thyroid Cancer

Interventions: Drug: durvalumab
Drug: tremelimumab
Radiation: Stereotactic Body Radiotherapy (SBRT)

First Posted Date: 2017-04-20

Last Posted Date: 2022-06-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 13

Registration Number: NCT03122496

Locations: 🇺🇸
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering @ Rockville, Rockville Centre, New York, United States

and more 5 locations

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Phase 2

Terminated

Conditions: Hodgkin Lymphoma

Interventions: Drug: Atezolizumab

First Posted Date: 2017-04-19

Last Posted Date: 2019-11-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT03120676

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States

and more 3 locations

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

Phase 3

Completed

Conditions: Surgery

Interventions: Drug: Neostigmine+glycopyrrolate
Drug: Sugammadex

First Posted Date: 2017-04-17

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 201

Registration Number: NCT03116997

Locations: 🇺🇸
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States

and more 1 locations

Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors

Terminated

Conditions: Healthy

Interventions: Other: Leukapheresis

First Posted Date: 2017-04-14

Last Posted Date: 2021-02-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1

Registration Number: NCT03114566

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

AI-Powered Research

Premium Access

Memorial Sloan Kettering Cancer Center

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer

A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors